Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 174164, 9 pages
http://dx.doi.org/10.1155/2015/174164
Review Article

Research Progress on Regulatory T Cells in Acute Kidney Injury

1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China
2Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China

Received 14 May 2015; Accepted 2 July 2015

Academic Editor: Eyad Elkord

Copyright © 2015 Yamei Wang and Yuhong Tao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Bellomo, J. A. Kellum, and C. Ronco, “Acute kidney injury,” The Lancet, vol. 380, no. 9843, pp. 756–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Liangos, R. Wald, J. W. O'Bell, L. Price, B. J. Pereira, and B. L. Jaber, “Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 1, pp. 43–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. S. Chawla and P. L. Kimmel, “Acute kidney injury and chronic kidney disease: an integrated clinical syndrome,” Kidney International, vol. 82, no. 5, pp. 516–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. G. Coca, S. Singanamala, and C. R. Parikh, “Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis,” Kidney International, vol. 81, no. 5, pp. 442–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. N. Martina, S. Noel, S. Bandapalle, A. R. Hamad, and H. Rabb, “T lymphocytes and acute kidney injury: update,” Nephron Clinical Practice, vol. 127, no. 1–4, pp. 51–55, 2014. View at Publisher · View at Google Scholar
  6. G. R. Kinsey and M. D. Okusa, “Expanding role of T cells in acute kidney injury,” Current Opinion in Nephrology and Hypertension, vol. 23, no. 1, pp. 9–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. R. Kinsey, L. Li, and M. D. Okusa, “Inflammation in acute kidney injury,” Nephron: Experimental Nephrology, vol. 109, no. 4, pp. e102–e107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bajwa, G. R. Kinsey, and M. D. Okusa, “Immune mechanisms and novel pharmacological therapies of acute kidney injury,” Current Drug Targets, vol. 10, no. 12, pp. 1196–1204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. V. Bonventre and L. Yang, “Cellular pathophysiology of ischemic acute kidney injury,” The Journal of Clinical Investigation, vol. 121, no. 11, pp. 4210–4221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. M. Wang, M. Hu, Y. Wang et al., “Regulatory T cells in renal disease,” International Journal of Clinical and Experimental Medicine, vol. 1, no. 4, pp. 294–304, 2008. View at Google Scholar
  11. A. K. Abbas, C. Benoist, J. A. Bluestone et al., “Regulatory T cells: recommendations to simplify the nomenclature,” Nature Immunology, vol. 14, no. 4, pp. 307–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. Shevach and A. M. Thornton, “tTregs, pTregs, and iTregs: similarities and differences,” Immunological Reviews, vol. 259, no. 1, pp. 88–102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Imanguli, E. W. Cowen, J. Rose et al., “Comparative analysis of FoxP3+ regulatory T cells in the target tissues and blood in chronic graft versus host disease,” Leukemia, vol. 28, no. 10, pp. 2016–2027, 2014. View at Google Scholar
  14. Y. Wang, Y. Wang, Y. Wang et al., “Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 1, pp. 38–47, 2014. View at Google Scholar · View at Scopus
  15. S. Wei, I. Kryczek, and W. Zou, “Regulatory T-cell compartmentalization and trafficking,” Blood, vol. 108, no. 2, pp. 426–431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. D. Sather, P. Treuting, N. Perdue et al., “Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease,” Journal of Experimental Medicine, vol. 204, no. 6, pp. 1335–1347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Campbell and M. A. Koch, “Phenotypical and functional specialization of FOXP3+ regulatory T cells,” Nature Reviews Immunology, vol. 11, no. 2, pp. 119–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. A. Vignali, L. W. Collison, and C. J. Workman, “How regulatory T cells work,” Nature Reviews Immunology, vol. 8, no. 7, pp. 523–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Bodor, T. Bopp, M. Vaeth et al., “Cyclic AMP underpins suppression by regulatory T cells,” European Journal of Immunology, vol. 42, no. 6, pp. 1375–1384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Shevach, “Mechanisms of foxp3+ T regulatory cell-mediated suppression,” Immunity, vol. 30, no. 5, pp. 636–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Oberle, N. Eberhardt, C. S. Falk, P. H. Krammer, and E. Suri-Payer, “Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling,” Journal of Immunology, vol. 179, no. 6, pp. 3578–3587, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pandiyan, L. Zheng, S. Ishihara, J. Reed, and M. J. Lenardo, “CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells,” Nature Immunology, vol. 8, no. 12, pp. 1353–1362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Ren, F. Ye, Z. Jiang, Y. Chu, S. Xiong, and Y. Wang, “Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+CD25+ regulatory T cells,” Cell Death and Differentiation, vol. 14, no. 12, pp. 2076–2084, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. I. Garín, C.-C. Chu, D. Golshayan, E. Cernuda-Morollón, R. Wait, and R. I. Lechler, “Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells,” Blood, vol. 109, no. 5, pp. 2058–2065, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Kubach, P. Lutter, T. Bopp et al., “Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function,” Blood, vol. 110, no. 5, pp. 1550–1558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. W. J. Grossman, J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley, “Human T regulatory cells can use the perforin pathway to cause autologous target cell death,” Immunity, vol. 21, no. 4, pp. 589–601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Gondek, L.-F. Lu, S. A. Quezada, S. Sakaguchi, and R. J. Noelle, “Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism,” Journal of Immunology, vol. 174, no. 4, pp. 1783–1786, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Sansom and L. S. K. Walker, “The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology,” Immunological Reviews, vol. 212, pp. 131–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Tai, F. Van Laethem, L. Pobezinsky et al., “Basis of CTLA-4 function in regulatory and conventional CD4+ T cells,” Blood, vol. 119, no. 22, pp. 5155–5163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Liang, C. Workman, J. Lee et al., “Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II,” The Journal of Immunology, vol. 180, no. 9, pp. 5916–5926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Q. Tran, D. D. Glass, G. Uzel et al., “Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function,” Journal of Immunology, vol. 182, no. 5, pp. 2929–2938, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Sarris, K. G. Andersen, F. Randow, L. Mayr, and A. G. Betz, “Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition,” Immunity, vol. 28, no. 3, pp. 402–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Wing, Y. Onishi, P. Prieto-Martin et al., “CTLA-4 control over Foxp3+ regulatory T cell function,” Science, vol. 322, no. 5899, pp. 271–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Yu, K. Harden, L. C. Gonzalez et al., “The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells,” Nature Immunology, vol. 10, no. 1, pp. 48–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Shalev, K. M. Wong, K. Foerster et al., “The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis,” Hepatology, vol. 49, no. 2, pp. 387–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Shalev, H. Liu, C. Koscik et al., “Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis,” Journal of Immunology, vol. 180, no. 1, pp. 249–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Wang, K. Pan, and J.-C. Xia, “Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape,” Chinese Journal of Cancer, vol. 28, no. 2, pp. 184–187, 2009. View at Google Scholar · View at Scopus
  38. S. Deaglio, K. M. Dwyer, W. Gao et al., “Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression,” The Journal of Experimental Medicine, vol. 204, no. 6, pp. 1257–1265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ohta, R. Kini, A. Ohta, M. Subramanian, M. Madasu, and M. Sitkovsky, “The development and immunosuppressive functions of CD4+CD25+FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway,” Frontiers in Immunology, vol. 3, article 190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Panther, S. Corinti, M. Idzko et al., “Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells,” Blood, vol. 101, no. 10, pp. 3985–3990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. G. R. Kinsey, R. Sharma, L. Huang et al., “Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1744–1753, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. R. M. Monteiro, N. O. Camara, M. M. Rodrigues et al., “A role for regulatory T cells in renal acute kidney injury,” Transplant Immunology, vol. 21, no. 1, pp. 50–55, 2009. View at Google Scholar
  43. M. T. Gandolfo, H. R. Jang, S. M. Bagnasco et al., “Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury,” Kidney International, vol. 76, no. 7, pp. 717–729, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. T. Gandolfo, H. R. Jang, S. M. Bagnasco et al., “Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion,” Transplant Immunology, vol. 23, no. 1-2, pp. 45–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Jun, W. Ke, L. Qingshu et al., “Protective effect of CD4+CD25highCD127low regulatory T cells in renal ischemia-reperfusion injury,” Cellular Immunology, vol. 289, no. 1-2, pp. 106–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. V. Bonventre, “Kidney ischemic preconditioning,” Current Opinion in Nephrology and Hypertension, vol. 11, no. 1, pp. 43–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. G. R. Kinsey, L. Huang, A. L. Vergis, L. Li, and M. D. Okusa, “Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney,” Kidney International, vol. 77, no. 9, pp. 771–780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Y. Cho, H. M. Choi, S. Y. Lee, M. G. Kim, H.-K. Kim, and S.-K. Jo, “The role of Tregs and CD11c+ macrophages/dendritic cells in ischemic preconditioning of the kidney,” Kidney International, vol. 78, no. 10, pp. 981–992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Grenz, H. Osswald, T. Eckle et al., “The reno-vascular A2B adenosine receptor protects the kidney from ischemia,” PLoS Medicine, vol. 5, no. 6, article e137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Lee, D. Nho, H.-S. Chung et al., “CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice,” Kidney International, vol. 78, no. 11, pp. 1100–1109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S.-Y. Lee, Y.-S. Lee, H.-M. Choi et al., “Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury,” Critical Care Medicine, vol. 40, no. 11, pp. 2997–3006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Cho, J. H. Lee, H. J. Lim et al., “Soluble CD25 is increased in patients with sepsis-induced acute kidney injury,” Nephrology, vol. 19, no. 6, pp. 318–324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Wan, W. J. Huang, W. Chen et al., “IL-10 deiciency increases renal ischemia-reperfusion injury,” Nephron Experimental Nephrology, vol. 128, no. 1-2, pp. 37–45, 2014. View at Publisher · View at Google Scholar
  54. G. R. Kinsey, L. Huang, K. Jaworska et al., “Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection,” Journal of the American Society of Nephrology, vol. 23, no. 9, pp. 1528–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Jaworska, J. Ratajczak, L. Huang et al., “Both PD-1 ligands protect the kidney from ischemia reperfusion injury,” Journal of Immunology, vol. 194, no. 1, pp. 325–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. L. S. K. Walker, “Treg and CTLA-4: two intertwining pathways to immune tolerance,” Journal of Autoimmunity, vol. 45, pp. 49–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. L.-W. Lai, K.-C. Yong, and Y.-H. H. Lien, “Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury,” Kidney International, vol. 81, no. 10, pp. 983–992, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Rabb, “The promise of immune cell therapy for acute kidney injury,” Journal of Clinical Investigation, vol. 122, no. 11, pp. 3852–3854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. C. H. June and B. R. Blazar, “Clinical application of expanded CD4+25+ cells,” Seminars in Immunology, vol. 18, no. 2, pp. 78–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Li, Y. Gan, B.-L. Sun et al., “Adoptive regulatory T-cell therapy protects against cerebral ischemia,” Annals of Neurology, vol. 74, no. 3, pp. 458–471, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. T. J. Murphy, N. N. Choileain, Y. Zang, J. A. Mannick, and J. A. Lederer, “CD4+CD25+ regulatory T cells control innate immune reactivity after injury,” Journal of Immunology, vol. 174, no. 5, pp. 2957–2963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Mahajan, Y. Wang, X. Qin et al., “CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2731–2741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Wolf, K. Hochegger, A. M. Wolf et al., “CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1360–1370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. K. J. Scalapino, Q. Tang, J. A. Bluestone, M. L. Bonyhadi, and D. I. Daikh, “Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells,” Journal of Immunology, vol. 177, no. 3, pp. 1451–1459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Yang, H. Bai, Y. Wang et al., “Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries,” Journal of Surgical Research, vol. 184, no. 2, pp. 832–837, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. W. Liu, A. L. Putnam, Z. Xu-yu et al., “CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells,” The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1701–1711, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Trzonkowski, M. Bieniaszewska, J. Juścińska et al., “First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127 T regulatory cells,” Clinical Immunology, vol. 133, no. 1, pp. 22–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. B. D. Singer, L. S. King, and F. R. D'Alessio, “Regulatory T cells as immunotherapy,” Frontiers in Immunology, vol. 5, article 46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Di Ianni, F. Falzetti, A. Carotti et al., “Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation,” Blood, vol. 117, no. 14, pp. 3921–3928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Di Ianni, F. Falzetti, A. Carotti et al., “Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation,” Best Practice and Research: Clinical Haematology, vol. 24, no. 3, pp. 459–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Marek-Trzonkowska, M. A. Wujtewicz, M. Myśliwiec et al., “Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children,” Diabetes Care, vol. 35, no. 9, pp. 1817–1820, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. C. G. Brunstein, J. S. Miller, Q. Cao et al., “Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics,” Blood, vol. 117, no. 3, pp. 1061–1070, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Zhou, S. L. Bailey-Bucktrout, L. T. Jeker et al., “Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo,” Nature Immunology, vol. 10, no. 9, pp. 1000–1007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Komatsu, M. E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann, and S. Hori, “Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1903–1908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Golab, D. Leveson-Gower, X.-J. Wang et al., “Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications,” International Immunopharmacology, vol. 16, no. 3, pp. 371–375, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Lee, E.-J. Lee, H. Kim et al., “Bee venom-associated Th1/Th2 immunoglobulin class switching results in immune tolerance of NZB/W F1 murine lupus nephritis,” American Journal of Nephrology, vol. 34, no. 2, pp. 163–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Kim, G. Lee, S. Park et al., “Bee venom mitigates cisplatin-induced nephrotoxicity by regulating CD4+CD25+Foxp3+ regulatory T cells in mice,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 879845, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Kim, H. Lee, G. Lee et al., “Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor,” Kidney International, 2015. View at Publisher · View at Google Scholar
  79. M.-G. Kim, S. Y. Lee, Y. S. Ko et al., “CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury,” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 111–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. K. E. Webster, S. Walters, R. E. Kohler et al., “In vivo expansion of t reg cells with il-2-mab complexes: induction of resistance to eae and long-term acceptance of islet allografts without immunosuppression,” The Journal of Experimental Medicine, vol. 206, no. 4, pp. 751–760, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. M.-G. Kim, T. Y. Koo, J.-J. Yan et al., “IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells,” Journal of the American Society of Nephrology, vol. 24, no. 10, pp. 1529–1536, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Baban, J. Y. Liu, and M. S. Mozaffari, “Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 303, no. 11, pp. R1136–R1146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. E. Gonzalez-Rey, M. A. Gonzalez, N. Varela et al., “Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 241–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. S. A. Patel, J. R. Meyer, S. J. Greco, K. E. Corcoran, M. Bryan, and P. Rameshwar, “Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-β,” Journal of Immunology, vol. 184, no. 10, pp. 5885–5894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Zuo, X. Liu, Z. Shou et al., “Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis,” International Journal of Molecular Medicine, vol. 32, no. 6, pp. 1337–1344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Hu, L. Zhang, N. Wang et al., “Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions,” Kidney International, vol. 84, no. 3, pp. 521–531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. B. Liu, X. Wu, B. Liu et al., “MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 11, pp. 1692–1704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Liang, W. Wang, and X. Gou, “MicroRNA 26a modulates regulatory T cells expansion and attenuates renal ischemia–reperfusion injury,” Molecular Immunology, vol. 65, no. 2, pp. 321–327, 2015. View at Publisher · View at Google Scholar
  89. A. Javeed, B. Zhang, Y. Qu et al., “The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice,” Transplant Immunology, vol. 20, no. 4, pp. 253–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. N. A. Forward, S. J. Furlong, Y. Yang, T.-J. Lin, and D. W. Hoskin, “Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells,” Journal of Leukocyte Biology, vol. 87, no. 1, pp. 117–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. A. E. Pedersen, K. Holmstrøm, F. Jørgensen, S. S. Jensen, and M. Gad, “Development of assay platforms for in vitro screening of Treg modulating potential of pharmacological compounds,” Immunopharmacology and Immunotoxicology, vol. 37, no. 1, pp. 63–71, 2015. View at Publisher · View at Google Scholar · View at Scopus